Evidence map›Paper›PMID 31123291›Full record

ArticleScientific reports2019

Sphingosine Kinase 2 Phosphorylation of FTY720 is Unnecessary for Prevention of Light-Induced Retinal Damage.

Hui Qi, Jerome Cole, Richard C Grambergs, John R Gillenwater, Koushik Mondal, Sufiya Khanam, Soma Dutta, Megan Stiles, Richard L Proia, Jeremy Allegood and 1 more

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.3field-weighted citation impact, top 44% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Light as a Mediator of Acute and Chronic Retina Degeneration.Advances in experimental medicine and biology · 2025
    Review
  3. Article
  4. Ophthalmic Nanoemulsion Fingolimod Formulation for Topical Application.Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics · 2024
    Article
  5. Article
  6. Article
  7. Review
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 1 country.

Hui QiDepartment of Ophthalmology, University of Oklahoma Health Sciences Center (OUHSC), Oklahoma City, OK, 73104, USA.
Jerome ColeDepartment of Ophthalmology, University of Tennessee Health Science Center, Memphis, TN, 38163, USA.
Richard C GrambergsDepartment of Ophthalmology, University of Tennessee Health Science Center, Memphis, TN, 38163, USA.
John R GillenwaterDepartment of Ophthalmology, University of Tennessee Health Science Center, Memphis, TN, 38163, USA.
Koushik MondalDepartment of Ophthalmology, University of Tennessee Health Science Center, Memphis, TN, 38163, USA.
Sufiya KhanamDepartment of Ophthalmology, University of Tennessee Health Science Center, Memphis, TN, 38163, USA.
Soma DuttaDepartment of Ophthalmology, University of Tennessee Health Science Center, Memphis, TN, 38163, USA.
Megan StilesDepartment of Ophthalmology, University of Oklahoma Health Sciences Center (OUHSC), Oklahoma City, OK, 73104, USA.
Richard L ProiaGenetics of Development and Disease Branch, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD, 20892, USA.
Jeremy AllegoodDepartment of Biochemistry and Molecular Biology, Virginia Commonwealth University School of Medicine, Richmond, VA, 2329, USA.
Nawajes MandalDepartment of Ophthalmology, University of Oklahoma Health Sciences Center (OUHSC), Oklahoma City, OK, 73104, USA. nmandal@uthsc.edu.ORCID http://orcid.org/0000-0003-4489-7748
University of Tennessee Health Science Center · USUniversity of Oklahoma Health Sciences Center · USNational Institutes of Health · USVirginia Commonwealth University · US

Funding

Virus Vector Shared ResourceP30CA016059 · NCI · VIRGINIA COMMONWEALTH UNIVERSITY · PI Kim Felder Rhoads · 1985 to 2026
$51.0M
Sphingolipid Biology of NeurodegenerationZIADK056016 · NIDDK · NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES · PI PROIA, RICHARD · 2009 to 2025
$21.3M
Mouse Models of Novel Sphingolipid Biology and Disease MechanismsZIADK056014 · NIDDK · NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES · PI PROIA, RICHARD · 2009 to 2025
$10.6M
P30-CENTER CORE GRANT FOR VISION RESEARCHP30EY021725 · NEI · UNIVERSITY OF OKLAHOMA HLTH SCIENCES CTR · PI Michelle C Callegan, MICHAEL H ELLIOTT · 2011 to 2026
$10.5M
Sphingolipid Metabolism and Signaling in the RetinaR01EY022071 · NEI · UNIVERSITY OF TENNESSEE HEALTH SCI CTR · PI MANDAL, NAWAJES · 2012 to 2016
$1.8M
Sphingolipid signaling in corneal wound healing and fibrosisR21EY025256 · NEI · UNIVERSITY OF OKLAHOMA HLTH SCIENCES CTR · PI KARAMICHOS, DIMITRIOS, MANDAL, NAWAJES · 2015 to 2016
$429k
NCI NIH HHS P30 CA016059NEI NIH HHS P30 EY021725NEI NIH HHS R01 EY022071NEI NIH HHS R21 EY025256
6 · The paper itself

Abstract

Mammalian Sphingosine kinase 2 is the primary enzyme responsible for phosphorylating FTY720 to its active form, FTY720-P. Systemic FTY720 treatment confers significant protection to murine retinas from light- and disease-mediated photoreceptor cell death. It is not clear whether FTY720-P, FTY720, or both are responsible for this photoreceptor protection. We investigated Sphingosine kinase 2 knockout (Sphk2 KO) mouse retinas, tested their sensitivity to light, and measured what degree of protection from light-induced damage they receive from systemic FTY720 treatment. Sphk2 KO retinas were found to be similar to their wild-type counterparts in sensitivity to light damage. Additionally, FTY720 treatment protected Sphk2 KO retinas from light-induced damage despite significant retardation of FTY720 phosphorylation in Sphk2 KO mice. We conclude that FTY720 serves an active role in preventing photoreceptor cell death. Furthermore, we conclude that the phosphorylation of FTY720 is not necessary to provide this protective effect.

Indexed as

LightAnimalsFingolimod HydrochlorideMiceMice, KnockoutPhosphorylationPhosphotransferases (Alcohol Group Acceptor)RetinaSphingosine 1 Phosphate Receptor ModulatorsSphingosine KinaseFingolimod HydrochloridePhosphotransferases (Alcohol Group Acceptor)Sphingosine 1 Phosphate Receptor ModulatorsSphingosine Kinasesphingosine kinase 2, mouse

Identifiers

PMID31123291
PMCPMC6533254
OpenAlexW2945775448

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.